Walvax Biotechnology Co Ltd Sustainability Reports
The company engages in the research and development, manufacturing, and distribution of human vaccines. Its portfolio includes pneumococcal, human papillomavirus (HPV), and meningococcal vaccines.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
LEI: 300300H82R2DIQXA8N24
FIGI: BBG001TC90J9
3 reports from 2023 to 2025